{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:06:11Z","timestamp":1794002771805,"version":"4.8.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008397","name":"Velux Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.preteyeres.2024.101323","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T16:54:17Z","timestamp":1733936057000},"page":"101323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3588-6350","authenticated-orcid":false,"given":"Thomas J.","family":"Corydon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toke","family":"Bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2024.101323_bib1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib3","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2024.101323_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/5.5.591","article-title":"Gene transfer into the mouse retina mediated by an adeno-associated viral vector","volume":"5","author":"Ali","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2024.101323_bib5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI34316","article-title":"Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice","volume":"118","author":"Allocca","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2024.101323_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.omtn.2022.02.019","article-title":"VEFGA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy","volume":"28","author":"Alsing","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2024.101323_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-med-012017-043332","article-title":"Entering the modern era of gene therapy","volume":"70","author":"Anguela","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2024.101323_bib9","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1007\/s00018-021-03796-9","article-title":"The complement system in age-related macular degeneration","volume":"78","author":"Armento","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081605","article-title":"Lentiviral vectors for ocular gene therapy","volume":"14","author":"Arsenijevic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2024.101323_bib11","article-title":"Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors","volume":"2","author":"Askou","year":"2015","journal-title":"Mol Ther-Meth Clin D"},{"key":"10.1016\/j.preteyeres.2024.101323_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.omtn.2019.01.012","article-title":"Suppression of choroidal neovascularization by AAV-based dual-acting antiangiogenic gene therapy","volume":"16","author":"Askou","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2024.101323_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41434-020-0168-2","article-title":"Retinal gene therapy: an eye-opener of the 21st century","volume":"28","author":"Askou","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.omtm.2023.08.007","article-title":"Toward lentiviral vectors for antiangiogenic ocular gene therapy","volume":"30","author":"Askou","year":"2023","journal-title":"Mol Ther Meth Clin D"},{"key":"10.1016\/j.preteyeres.2024.101323_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jgm.2678","article-title":"Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA","volume":"14","author":"Askou","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1209527","article-title":"Caspase-9 inhibition confers stronger neuronal and vascular protection compared to VEGF neutralization in a mouse model of retinal vein occlusion","volume":"17","author":"Avrutsky","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41434-024-00461-1","article-title":"Stable inhibition of choroidal neovascularization by adeno-associated virus 2\/8-vectored bispecific molecules","volume":"31","author":"Bai","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib18","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/aos.15641","article-title":"Visual acuity and causes of central visual loss in the adult Danish population 2020-2022. Results from the FORSYN study","volume":"101","author":"Bek","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/gt.2010.56","article-title":"rAAV2\/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters","volume":"17","author":"Beltran","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.gt.3302030","article-title":"Immune response following intraocular delivery of recombinant viral vectors","volume":"10","author":"Bennett","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s40265-022-01788-y","article-title":"Valoctocogene roxaparvovec: first approval","volume":"82","author":"Blair","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.preteyeres.2024.101323_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00125-003-1040-9","article-title":"Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy","volume":"46","author":"Boehm","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.preteyeres.2024.101323_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamaophthalmol.2018.6902","article-title":"Immune response and intraocular inflammation in patients with leber hereditary optic neuropathy treated with intravitreal injection of recombinant adeno-associated virus 2 carrying the ND4 gene A secondary analysis of a phase 1\/2 clinical trial","volume":"137","author":"Bouquet","year":"2019","journal-title":"Jama Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101323_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for wiskott-aldrich syndrome-long-term efficacy and genotoxicity (vol 6, 227ra33, 2014)","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMct0908432","article-title":"Panretinal photocoagulation for proliferative diabetic retinopathy","volume":"365","author":"Bressler","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib28","first-page":"198","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2","volume":"119","author":"Bressler","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib29","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.17.6.061219","article-title":"Real-time temperature determination during retinal photocoagulation on patients","volume":"17","author":"Brinkmann","year":"2012","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.preteyeres.2024.101323_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors-Implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib31","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Tar"},{"key":"10.1016\/j.preteyeres.2024.101323_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group","volume":"98","year":"1984","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207489119","article-title":"DARPP32, a target of hyperactive mTORC1 in the retinal pigment epithelium","volume":"119","author":"Cai","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2024.101323_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study","volume":"28","author":"Campochiaro","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib35","article-title":"Evaluating efficiencies of dual AAV approaches for retinal targeting","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front Neurosci-Switz"},{"key":"10.1016\/j.preteyeres.2024.101323_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/hum.2017.154","article-title":"Synthetic adeno-associated viral vector efficiently targets mouse and nonhuman primate retina in vivo","volume":"29","author":"Carvalho","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib37","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1167\/iovs.05-1610","article-title":"Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD","volume":"47","author":"Cashman","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41581-022-00636-2","article-title":"Advances in CRISPR therapeutics","volume":"19","author":"Chavez","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib39","article-title":"Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy","volume":"23","author":"Chehelgerdi","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.preteyeres.2024.101323_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib41","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2024.101323_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ICU.0b013e32832d25b3","article-title":"Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"20","author":"Ciulla","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib43","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/mt.2012.93","article-title":"Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy","volume":"20","author":"Corrigan-Curay","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.omtn.2023.07.018","article-title":"25 years of maturation: a systematic review of RNAi in the clinic","volume":"33","author":"Corydon","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2024.101323_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2024.101323_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100952","article-title":"Implications of genetic variation in the complement system in age-related macular degeneration","volume":"84","author":"de Jong","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/19420862.2016.1268305","article-title":"Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration","volume":"9","author":"Ding","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.preteyeres.2024.101323_bib48","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1172\/JCI129085","article-title":"AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression","volume":"129","author":"Ding","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2024.101323_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2024.101323_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2024.101323_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib52","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2024.101323_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjophthalmol-2021-egsguidelines","article-title":"European glaucoma society terminology and guidelines for glaucoma, 5th edition","volume":"105","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2024.101323_bib56","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group","volume":"103","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.63.9.11","article-title":"Animal models of choroidal neovascularization: a systematic review","volume":"63","author":"Fabian-Jessing","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib58","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.7150\/thno.45192","article-title":"Targeting the Notch and TGF-beta signaling pathways to prevent retinal fibrosis in vitro and in vivo","volume":"10","author":"Fan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.preteyeres.2024.101323_bib59","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2024.101323_bib60","first-page":"772","article-title":"Outcome measures and their application in clinical trials for retinal degenerative diseases - Outline, review, and perspective","volume":"25","author":"Fishman","year":"2005","journal-title":"Retina-J Ret Vit Dis"},{"key":"10.1016\/j.preteyeres.2024.101323_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2017.098","article-title":"Manufacture of third-generation lentivirus for preclinical use, with process development considerations for translation to good manufacturing practice","volume":"29","author":"Gandara","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.preteyeres.2024.101323_bib62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2217T to G\u2217C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2024.101323_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2024.101323_bib64","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1016\/j.ophtha.2016.05.054","volume":"124","author":"Gillies","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101323_bib65","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1096\/fj.202000612R","article-title":"MTOR-initiated metabolic switch and degeneration in the retinal pigment epithelium","volume":"34","author":"Go","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.preteyeres.2024.101323_bib66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.exer.2011.03.006","article-title":"Optimization of laser-induced choroidal neovascularization in African green monkeys","volume":"92","author":"Goody","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib67","doi-asserted-by":"crossref","DOI":"10.3791\/61806-v","article-title":"Behavioral assessment of visual function via optomotor response and cognitive function via Y-maze in diabetic rats","author":"Gudapati","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.preteyeres.2024.101323_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2024.101323_bib168","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1093\/nar\/gkad676","article-title":"Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR\/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification","volume":"51","author":"Haldrup","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib69","article-title":"Subretinal AAV delivery of RNAi-therapeutics targeting VEGFA reduces choroidal neovascularization in a large animal model","volume":"32","author":"Haldrup","year":"2024","journal-title":"Mol Ther Meth Clin D"},{"key":"10.1016\/j.preteyeres.2024.101323_bib70","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.7.29","article-title":"Subretinal saline protects the neuroretina from thermic damage during laser induction of experimental choroidal neovascularization in pigs","volume":"10","author":"Hansen","year":"2021","journal-title":"Transl Vis Sci Techn"},{"key":"10.1016\/j.preteyeres.2024.101323_bib71","article-title":"Future perspectives of prime editing for the treatment of inherited retinal diseases","volume":"12","author":"Hansen","year":"2023","journal-title":"Cells-Basel"},{"key":"10.1016\/j.preteyeres.2024.101323_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183269","article-title":"Analysis of AgoshRNA maturation and loading into Ago2","volume":"12","author":"Harwig","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2024.101323_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00920049","article-title":"Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study","volume":"228","author":"Hayreh","year":"1990","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib74","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/CS20130463","article-title":"PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases","volume":"128","author":"He","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib75","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2024.101323_bib76","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2024.101323_bib77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","article-title":"Etranacogene dezaparvovec: first approval","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.preteyeres.2024.101323_bib78","doi-asserted-by":"crossref","first-page":"eadd4623","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2024.101323_bib79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib80","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(02)01549-0","article-title":"Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration","volume":"134","author":"Holekamp","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtn.2017.08.016","article-title":"In vivo knockout of the vegfa gene by lentiviral delivery of CRISPR\/Cas9 in mouse retinal pigment epithelium cells","volume":"9","author":"Holmgaard","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2024.101323_bib82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ymthe.2020.09.032","article-title":"Targeted knockout of the VegfA gene in the retina by subretinal injection of RNP complexes containing Cas9 protein and modified sgRNAs","volume":"29","author":"Holmgaard","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib83","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2024.101323_bib84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/IJN.S428684","article-title":"Topical application of cell-penetrating peptide modified anti-VEGF drug alleviated choroidal neovascularization in mice","volume":"19","author":"Hu","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.preteyeres.2024.101323_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archophthalmol.2007.29","article-title":"Effect of pulse duration on size and character of the lesion in retinal photocoagulation","volume":"126","author":"Jain","year":"2008","journal-title":"Arch Ophthalmol-Chic"},{"key":"10.1016\/j.preteyeres.2024.101323_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109590","article-title":"Porcine models of choroidal neovascularization: a systematic review","volume":"234","author":"Jakobsen","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib88","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","article-title":"Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization","volume":"168","author":"Jo","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib89","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.omtn.2018.11.013","article-title":"Efficient knockdown and lack of passenger strand activity by dicer-independent shRNAs expressed from pol II-driven MicroRNA scaffolds","volume":"14","author":"Kaadt","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2024.101323_bib90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15548627.2022.2069437","article-title":"Autophagy in age-related macular degeneration","volume":"19","author":"Kaarniranta","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.preteyeres.2024.101323_bib91","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6317","article-title":"Evaluation of AAV-DJ vector for retinal gene therapy","volume":"7","author":"Katada","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.preteyeres.2024.101323_bib92","article-title":"Continuous intraocular drug delivery lasting over a decade: ciliary neurotrophic factor (CNTF) secreted from neurotech's NT-501 implanted in subjects with retinal degenerative disorders","volume":"64","author":"Kauper","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib93","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of luxturna (and zolgensma and glybera): where are we, and how did we get here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.preteyeres.2024.101323_bib94","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.ymthe.2023.10.001","article-title":"Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion","volume":"31","author":"Kellish","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib95","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/s41433-023-02553-5","article-title":"The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results","volume":"37","author":"Khanani","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2024.101323_bib96","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-0420.2005.00566.x","article-title":"A new animal model of choroidal neovascularization","volume":"83","author":"Kiilgaard","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2024.101323_bib97","article-title":"Human vascular endothelial growth factor A165 expression induces the mouse model of neovascular age-related macular degeneration","volume":"9","author":"Kokki","year":"2018","journal-title":"Genes-Basel"},{"key":"10.1016\/j.preteyeres.2024.101323_bib98","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2024.101323_bib99","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/s41467-018-04175-y","article-title":"CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration","volume":"9","author":"Koo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2024.101323_bib100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"FROM THE ANALYST'S COUCH the clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2024.101323_bib101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00006982-198200230-00007","article-title":"Panretinal photocoagulation and retinal oxygenation","volume":"2","author":"Landers","year":"1982","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2024.101323_bib102","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00417-006-0518-9","article-title":"Surgical induction of choroidal neovascularization in a porcine model","volume":"245","author":"Lassota","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib104","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.visres.2007.07.026","article-title":"Cone-specific expression using a human red opsin promoter in recombinant AAV","volume":"48","author":"Li","year":"2008","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib105","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Tar"},{"key":"10.1016\/j.preteyeres.2024.101323_bib106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101323_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R700039200","article-title":"The mechanism of human nonhomologous DNA end joining","volume":"283","author":"Lieber","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2024.101323_bib108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.preteyeres.2024.101323_bib109","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ymthe.2020.06.029","article-title":"Gene therapy intervention in neovascular eye disease: a recent update","volume":"28","author":"Lin","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib110","article-title":"An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species","volume":"15","author":"Luo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2024.101323_bib111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib112","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib113","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2017.10.012","article-title":"Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients","volume":"26","author":"Marcucci","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib114","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib115","article-title":"Validation of a rod photoreceptor-specific promoter for CRISPR gene therapy","volume":"63","author":"McClements","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib116","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jxb\/erac322","article-title":"Keeping up with the miRNAs: current paradigms of the biogenesis pathway","volume":"74","author":"Mencia","year":"2023","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.preteyeres.2024.101323_bib117","first-page":"137","article-title":"The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases","volume":"68","author":"Michaelson","year":"1948","journal-title":"Trans. Ophthalmol. Soc. U. K."},{"key":"10.1016\/j.preteyeres.2024.101323_bib118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8+ T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib119","article-title":"Imaging of temperature distribution and retinal tissue changes during photocoagulation by high speed OCT","volume":"7889","author":"M\u00fcller","year":"2011","journal-title":"Proc. SPIE"},{"key":"10.1016\/j.preteyeres.2024.101323_bib120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13543784.2021.1879791","article-title":"Faricimab: an investigational agent targeting the Tie-2\/angiopoietin pathway and VEGF-A for the treatment of retinal diseases","volume":"30","author":"Nicolo","year":"2021","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.preteyeres.2024.101323_bib121","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9394(02)01568-4","article-title":"Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy","volume":"134","author":"Ogata","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib122","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.msec.2017.04.068","article-title":"Non-viral strategies for ocular gene delivery","volume":"77","author":"Oliveira","year":"2017","journal-title":"Mat Sci Eng C-Mater"},{"key":"10.1016\/j.preteyeres.2024.101323_bib123","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib124","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib125","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/s41598-023-29014-z","article-title":"CRISPR\/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101323_bib126","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2022.02.013","article-title":"Three-Year safety results of SAR422459 (EIAV-ABCA4) gene therapy in patients with ABCA4-associated stargardt disease: an open-label dose-escalation phase I\/IIa clinical trial, cohorts 1-5","volume":"240","author":"Parker","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib127","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.preteyeres.2024.101323_bib130","first-page":"210","article-title":"Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model","volume":"9","author":"Reich","year":"2003","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2024.101323_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42386-0","article-title":"mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy","volume":"14","author":"Riedmayr","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2024.101323_bib132","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-Year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2024.101323_bib133","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2024.101323_bib134","article-title":"Epiretinal placement of fibrin hydrogel-encapsulated adeno-associated virus transduces retinal pigment epithelium in the domestic pig, ARVO Annual Meeting","author":"Scruggs","year":"2024","journal-title":"Investigative Ophthalmology & Visual Science, Seattle"},{"key":"10.1016\/j.preteyeres.2024.101323_bib135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2024.101323_bib136","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1038\/ncomms9430","article-title":"Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects","volume":"6","author":"Shang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2024.101323_bib137","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1038\/s41598-018-27329-w","article-title":"Optimization of optomotor response-based visual function assessment in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101323_bib138","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9394(02)01452-6","article-title":"Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin","volume":"134","author":"Spaide","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112779","article-title":"ALKBH5 causes retinal pigment epithelium anomalies and choroidal neovascularization in age-related macular degeneration via the AKT\/mTOR pathway","volume":"42","author":"Sun","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.preteyeres.2024.101323_bib140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib141","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jsb.2005.05.005","article-title":"PEDF and the serpins: phylogeny, sequence conservation, and functional domains","volume":"151","author":"Tombran-Tink","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib142","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-4835(91)90248-D","article-title":"Pedf - a pigment epithelium-derived factor with potent neuronal differentiative activity","volume":"53","author":"Tombran-Tink","year":"1991","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib143","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.exer.2014.05.003","article-title":"A detailed three-step protocol for live imaging of intracellular traffic in polarized primary porcine RPE monolayers","volume":"124","author":"Toops","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2024.101323_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav4523","article-title":"Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina","volume":"11","author":"Tornabene","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.122.001234","article-title":"RNAi-based therapeutics and novel RNA bioengineering technologies","volume":"384","author":"Traber","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.preteyeres.2024.101323_bib146","first-page":"174","article-title":"Screening of CRISPR\/Cas base editors to target the AMD high-risk Y402H complement factor H variant","volume":"25","author":"Tran","year":"2019","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2024.101323_bib147","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib148","first-page":"CD009300","article-title":"Complement inhibitors for age-related macular degeneration","volume":"6","author":"Tzoumas","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2024.101323_bib149","doi-asserted-by":"crossref","first-page":"F1166","DOI":"10.1152\/ajprenal.00375.2007","article-title":"Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy","volume":"294","author":"Wang","year":"2008","journal-title":"Am J Physiol-Renal"},{"key":"10.1016\/j.preteyeres.2024.101323_bib150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.add8643","article-title":"CRISPR technology: a decade of genome editing is only the beginning","volume":"379","author":"Wang","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2024.101323_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102236","article-title":"Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes","volume":"35","author":"Wang","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2024.101323_bib152","article-title":"mTOR signalling pathway: a potential therapeutic target for ocular neurodegenerative diseases","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.preteyeres.2024.101323_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107939","article-title":"Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration","volume":"26","author":"Wei-Zhang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.preteyeres.2024.101323_bib154","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2024.101323_bib155","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaophthalmol.2023.2421","article-title":"Effect of high-dose intravitreal aflibercept, 8 mg, in patients with neovascular age-related macular degeneration: the phase 2 CANDELA randomized clinical trial","volume":"141","author":"Wykoff","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2024.101323_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1310050","article-title":"Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies","volume":"10","author":"Xia","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2024.101323_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/ctd2.278","article-title":"CRISPR-based gene therapy for wet age-related macular degeneration in mouse model","volume":"4","author":"Xie","year":"2024","journal-title":"Clin Transl Discov"},{"key":"10.1016\/j.preteyeres.2024.101323_bib158","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/hum.2015.130","article-title":"Cone-specific promoters for gene therapy of achromatopsia and other retinal diseases","volume":"27","author":"Ye","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib159","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.preteyeres.2024.101323_bib160","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/mt.2012.194","article-title":"Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union","volume":"20","author":"Yl\u00e4-Herttuala","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib161","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1167\/iovs.14-14758","article-title":"Subcellular distribution and activity of mechanistic target of rapamycin in aged retinal pigment epithelium","volume":"55","author":"Yu","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2024.101323_bib162","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcell.2018.00053","article-title":"In vivo applications of CRISPR-based genome editing in the retina","volume":"6","author":"Yu","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib163","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41434-019-0094-3","article-title":"AAVrh-10 transduces outer retinal cells in rodents and rabbits following intravitreal administration","volume":"26","author":"Zeng","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2024.101323_bib164","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/s41598-020-59244-4","article-title":"Dysregulated metabolic pathways in age-related macular degeneration","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2024.101323_bib165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/JME-08-0011","article-title":"Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein","volume":"41","author":"Zhang","year":"2008","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.preteyeres.2024.101323_bib166","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI44303","article-title":"mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice","volume":"121","author":"Zhao","year":"2011","journal-title":"J. Clin. Invest."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946224000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946224000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T22:23:39Z","timestamp":1736288619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946224000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":167,"alternative-id":["S1350946224000880"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101323","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101323"}}